Inhibitory effect of ursolic acid derivatives on recombinant human aldose reductase Full article
Journal |
Russian Journal of Bioorganic Chemistry
ISSN: 1068-1620 |
||||
---|---|---|---|---|---|
Output data | Year: 2011, Volume: 37, Number: 5, Pages: 569-577 Pages count : DOI: 10.1134/S1068162011050050 | ||||
Tags | aldose reductase; N-(3 beta-hydroxyurs-12-en-28-oyl)-4-aminobutyric acid; ursolic acid derivatives; diabetic complications | ||||
Authors |
|
||||
Affiliations |
|
Abstract:
Aldose reductase (AR) is the first enzyme in the polyol pathway. AR has been reported to play an important role in the pathogenesis of diabetic complications. Ursolic acid and fourteen synthetic derivatives with ursane skeleton were tested for recombinant human aldose reductase (rhAR) inhibitory activity for development of diabetic complications. Among them, N-(3 beta-hydroxyurs-12-en-28-oyl)-4-aminobutyric acid (XV) showed most potent rhAR inhibitory activity in vitro. Inhibition mode of N-(3 beta-hydroxyurs-12-en-28-oyl)-4-aminobutyric acid (XV) was tested uncompetitively by kinetic analysis using the Lineweaver-Burk plots. Ursolic acid derivative N-(3 beta-hydroxyurs-12-en-28-oyl)-4-aminobutyric acid is able to inhibit rhAR uncompetitively and could be offered as a lead compound for AR inhibition.
Cite:
Lee E.H.
, Popov S.A.
, Lee J.Y.
, Shpatov A.V.
, Kukina T.P.
, Kang S.W.
, Pan C.H.
, Um B.H.
, Jung S.H.
Inhibitory effect of ursolic acid derivatives on recombinant human aldose reductase
Russian Journal of Bioorganic Chemistry. 2011. V.37. N5. P.569-577. DOI: 10.1134/S1068162011050050 WOS Scopus РИНЦ
Inhibitory effect of ursolic acid derivatives on recombinant human aldose reductase
Russian Journal of Bioorganic Chemistry. 2011. V.37. N5. P.569-577. DOI: 10.1134/S1068162011050050 WOS Scopus РИНЦ
Dates:
Published print: | Sep 1, 2011 |
Published online: | Oct 1, 2011 |
Identifiers:
Web of science | WOS:000295533200007 |
Scopus | 2-s2.0-80055000521 |
Elibrary | 18011095 |
OpenAlex | W2077366989 |